303 related articles for article (PubMed ID: 17706770)
21. Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene.
Sato A; Imaizumi M; Hoshi Y; Rikiishi T; Fujii K; Kizaki M; Kagechika H; Kakizuka A; Hayashi Y; Iinuma K
Leuk Res; 2004 Sep; 28(9):959-67. PubMed ID: 15234573
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines.
Wei YM; Ou YX; Bai H; Lu JH; Zheng RL
Acta Pharmacol Sin; 2001 Aug; 22(8):725-30. PubMed ID: 11749846
[TBL] [Abstract][Full Text] [Related]
23. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
Jing Y; Hellinger N; Xia L; Monks A; Sausville EA; Zelent A; Waxman S
Cancer Res; 2005 Sep; 65(17):7847-55. PubMed ID: 16140954
[TBL] [Abstract][Full Text] [Related]
24. Analysis of telomerase activity and RNA expression in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid.
Akiyama M; Yamada O; Yanagisawa T; Fujisawa K; Eto Y; Yamada H
Pediatr Blood Cancer; 2006 Apr; 46(4):506-11. PubMed ID: 15770638
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide inhibits ATRA-induced prostaglandin E2 and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia.
Habib A; Hamade E; Mahfouz R; Nasrallah MS; de Thé H; Bazarbachi A
Leukemia; 2008 Jun; 22(6):1125-30. PubMed ID: 18354491
[TBL] [Abstract][Full Text] [Related]
26. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
Huang X
Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
[TBL] [Abstract][Full Text] [Related]
28. Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
Cunha De Santis G; Tamarozzi MB; Sousa RB; Moreno SE; Secco D; Garcia AB; Lima AS; Faccioli LH; Falcão RP; Cunha FQ; Rego EM
Haematologica; 2007 Dec; 92(12):1615-22. PubMed ID: 18055984
[TBL] [Abstract][Full Text] [Related]
29. PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors.
Brugnoli F; Bovolenta M; Benedusi M; Miscia S; Capitani S; Bertagnolo V
J Cell Biochem; 2006 May; 98(1):160-73. PubMed ID: 16408290
[TBL] [Abstract][Full Text] [Related]
30. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner.
Wang ZG; Rivi R; Delva L; König A; Scheinberg DA; Gambacorti-Passerini C; Gabrilove JL; Warrell RP; Pandolfi PP
Blood; 1998 Sep; 92(5):1497-504. PubMed ID: 9716575
[TBL] [Abstract][Full Text] [Related]
31. Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines.
Ryu KH; Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Kie JH; Shin HY; Ahn HS
Pediatr Hematol Oncol; 2005; 22(7):609-21. PubMed ID: 16166054
[TBL] [Abstract][Full Text] [Related]
32. Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies.
Chen Z; Chen GQ; Shen ZX; Chen SJ; Wang ZY
Semin Hematol; 2001 Jan; 38(1):26-36. PubMed ID: 11172537
[TBL] [Abstract][Full Text] [Related]
33. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias.
Barber N; Belov L; Christopherson RI
Leuk Res; 2008 Feb; 32(2):315-22. PubMed ID: 17561254
[TBL] [Abstract][Full Text] [Related]
34. [Effects of arsenic trioxide on the subcellular localization of PML/PML-RARalpha protein in leukemic cells].
Ni J; Chen G; Zhu J; Zhong H; Tang W; Li X; Xiong S; Shen Z; Chen S; Wang Z; Chen L
Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):32-4. PubMed ID: 15622748
[TBL] [Abstract][Full Text] [Related]
35. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
[TBL] [Abstract][Full Text] [Related]
36. BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity.
Puccetti E; Güller S; Orleth A; Brüggenolte N; Hoelzer D; Ottmann OG; Ruthardt M
Cancer Res; 2000 Jul; 60(13):3409-13. PubMed ID: 10910048
[TBL] [Abstract][Full Text] [Related]
37. PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase.
Li L; Wang J; Ye RD; Shi G; Jin H; Tang X; Yi J
J Cell Physiol; 2008 Nov; 217(2):486-93. PubMed ID: 18636556
[TBL] [Abstract][Full Text] [Related]
38. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.
Chen GQ; Zhu J; Shi XG; Ni JH; Zhong HJ; Si GY; Jin XL; Tang W; Li XS; Xong SM; Shen ZX; Sun GL; Ma J; Zhang P; Zhang TD; Gazin C; Naoe T; Chen SJ; Wang ZY; Chen Z
Blood; 1996 Aug; 88(3):1052-61. PubMed ID: 8704214
[TBL] [Abstract][Full Text] [Related]
39. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621
[TBL] [Abstract][Full Text] [Related]
40. ICAT as a potential enhancer of monocytic differentiation: implications from the comparative proteome analysis of the HL60 cell line stimulated by all-trans retinoic acid and NSC67657.
Wang W; Zhang X; Deng K; Huang S; Mao X; Fu Y; Yi Z; Yan Y; Qiu Z
Cell Biochem Funct; 2009 Aug; 27(6):329-37. PubMed ID: 19569129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
